Nano-X Imaging Q3 2024 Earnings Preview
| NNOX Stock | USD 6.76 0.19 2.89% |
Slightly above 56% of all Nano X's investors are looking to take a long position. The analysis of overall sentiment of trading Nano X Imaging stock suggests that some investors are interested at this time. Nano X's investing sentiment can be driven by a variety of factors including economic data, Nano X's earnings reports, geopolitical events, and overall market trends.
Nano |
NNOX is set to announce Q3 earnings on 1121. Consensus estimates show potential growth in both EPS and revenue.
Read at seekingalpha.com
 |
Nano X Fundamental Analysis
We analyze Nano X's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nano X using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nano X based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Nano X is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Nano X Imaging Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nano X stock to make a market-neutral strategy. Peer analysis of Nano X could also be used in its relative valuation, which is a method of valuing Nano X by comparing valuation metrics with similar companies.
Peers
Nano X Related Equities
| MASS | 908 Devices | 6.19 | ||||
| DXCM | DexCom | 5.57 | ||||
| MGRM | Monogram Orthopaedics | 2.79 | ||||
| SYK | Stryker | 2.09 | ||||
| PACB | Pacific Biosciences | 2.07 | ||||
| ABT | Abbott Laboratories | 1.61 | ||||
| NVCR | Novocure | 1.32 | ||||
| MDT | Medtronic PLC | 1.30 | ||||
| EW | Edwards Lifesciences | 1.19 | ||||
| IART | Integra LifeSciences | 0.41 | ||||
| BSX | Boston Scientific | 0.33 | ||||
| ALGN | Align Technology | 1.18 | ||||
| HYPR | Hyperfine | 4.30 |
Additional Tools for Nano Stock Analysis
When running Nano X's price analysis, check to measure Nano X's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nano X is operating at the current time. Most of Nano X's value examination focuses on studying past and present price action to predict the probability of Nano X's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nano X's price. Additionally, you may evaluate how the addition of Nano X to your portfolios can decrease your overall portfolio volatility.